Remy Gross

Insider Reports History

Entity
Individual
Location
601 Genome Way Suite 2001, Huntsville, AL
Signature
/s/ Remy Gross
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Remy Gross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AgeX Therapeutics, Inc. Director Stock Option (right to buy) 157K Apr 1, 2024 Direct

Insider Reports Filed by Remy Gross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SER AgeX Therapeutics, Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
SER AgeX Therapeutics, Inc. Mar 26, 2024 0 $0 3 Apr 3, 2024 Director